(Q22299313)

2

Suzanne

Hurd

1 reference

8 February 2023

Peter J. Barnes

4

Peter J

Barnes

1 reference

8 February 2023

Sonia A. Buist

5

Sonia A

Buist

1 reference

8 February 2023

Peter Calverley

6

Peter

Calverley

1 reference

8 February 2023

Yoshinosuke Fukuchi

7

Yoshinosuke

Fukuchi

1 reference

8 February 2023

Christine Jenkins

8

Christine

Jenkins

1 reference

8 February 2023

Roberto Rodriguez-Roisin

9

Roberto

Rodriguez-Roisin

1 reference

8 February 2023

Jan Zielinski

11

Jan

American Journal of Respiratory and Critical Care Medicine

Zielinski

1 reference

8 February 2023

language of work or name

English

0 references

publication date

15 September 2007

0 references

published in

0 references

volume

176

0 references

page(s)

532-555

0 references

issue

6

0 references

cites work

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effectiveness of team-managed home-based primary care: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Can a Pulmonary Health Teaching Program Alter Patients’ Ability to Cope with COPD?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Passive smoking in obstructive respiratory disease in an industrialized urban population

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Theophylline concentrations in patients with acute exacerbation of COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Maternal exposure to biomass smoke and reduced birth weight in Zimbabwe.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A case-control study on the effect of exposure to different substances on the development of COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

COPD: can prevention be improved? Proposal for an integrated intervention strategy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Postoperative pulmonary complications

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Indoor air pollution and health in developing countries

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-68 and 1970-76

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomised controlled trial of respiratory rehabilitation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Functional evaluation before lung resection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A long-term prospective assessment of home nebulizer treatment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood Gases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Lung transplantation comes of age.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term oxygen therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Preoperative pulmonary evaluation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Physician-patient partnership in managing chronic illness

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

COPD in Japan: the Nippon COPD Epidemiology study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chemotherapy of bronchitis. Influence of penicillin and tetracycline administered daily, or intermittently for exacerbations. A report to the Research Committee of the British Tuberculosis Association by its Bronchitis Subcommittee

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

"Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Five-year winter chemoprophylaxis for chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Introducing tobacco cessation in developing countries: an overview of Project Quit Tobacco International

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Recent trends in physician diagnosed COPD in women and men in the UK.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A systematic review of the use of opioids in the management of dyspnoea.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Duplicate publication

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

COPD exacerbations.5: management

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Immune and inflammatory function in cigarette smokers

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

1 reference

7 January 2021

Helping people to stop smoking: the new smoking cessation guidelines.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

High-dose inhaled albuterol in severe chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The relationship between pneumonia in early childhood and impaired lung function in late adult life

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Corticosteroids contribute to muscle weakness in chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Pulmonary rehabilitation in patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Controlled trial of oral prednisone in outpatients with acute COPD exacerbation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Outcomes of advance directive education of pulmonary rehabilitation patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

1 reference

7 January 2021

Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immuno

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

1 reference

7 January 2021

The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

How is mechanical ventilation employed in the intensive care unit? An international utilization review

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Alteration in breathing pattern with progression of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

American Thoracic Society statement: occupational contribution to the burden of airway disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Post-bronchodilator spirometry reference values in adults and implications for disease management

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Spirometry in primary care: is it good enough to face demands like World COPD Day?: Table 1

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

COPD exacerbations: definitions and classifications.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Systemic effects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Impact of preventing exacerbations on deterioration of health status in COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Factors affecting survival of hospitalised patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Interpretative strategies for lung function tests

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Guidelines for the management of adult lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Shedding new light on wood smoke: a risk factor for respiratory health

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Epidemiology and costs of chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Chronic obstructive pulmonary disease: current burden and future projections.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Wood smoke exposure and risk of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Global burden of COPD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Gender difference in smoking effects on adult pulmonary function.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Functional evaluation of the lung resection candidate

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Physician perceptions and management of COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Toward a consensus definition for COPD exacerbations

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Airway inflammation and etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Salmeterol plus theophylline combination therapy in the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Systemic effects in COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Costs of COPD in Sweden according to disease severity.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

A controlled trial of ambroxol in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Systemic Effects of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

"Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Noninvasive positive pressure ventilation to treat respiratory failure

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-456SO

7 January 2021

10.1164/RCCM.200703-456SO

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

205441

205441

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference